Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,725
Closed -$910K 84
2022
Q1
$910K Buy
8,725
+487
+6% +$57K 0.73% 36
2021
Q4
$991K Sell
8,238
-413
-5% -$48.4K 0.61% 37
2021
Q3
$966K Buy
8,651
+240
+3% +$28.2K 0.58% 41
2021
Q2
$1.01M Buy
8,411
+703
+9% +$82.4K 0.69% 38
2021
Q1
$912K Buy
7,708
+483
+7% +$59.8K 0.72% 30
2020
Q4
$788K Buy
7,225
+1,812
+33% +$172K 0.66% 35
2020
Q3
$439K Buy
5,413
+1,161
+27% +$88.2K 0.42% 48
2020
Q2
$241K Buy
+4,252
New +$224K 0.49% 58

Other funds holding TSM

Prostatis Group's TSM Position: Q2 2022 in Review

Prostatis Group sold out of TSMC (TSM) in Q2 2022, closing a stake of 8,725 shares — an estimated $910K sold.

Prostatis Group first reported a position in TSM in Q2 2020 and held it in 8 quarters. The position peaked at $1.01M in Q2 2021. 1,375 funds tracked by Wall St. Rank hold TSM as of Q2 2022.

  • Prostatis Group reported no remaining TSMC position as of Q2 2022 after selling out during the quarter.
  • Prostatis Group sold 8,725 TSMC shares in Q2 2022, an estimated $910K.
  • Prostatis Group first reported a position in TSMC in Q2 2020 and held it in 8 quarters.
  • Prostatis Group's TSMC position peaked at $1.01M in Q2 2021.
  • 1,375 funds tracked by Wall St. Rank held TSMC as of Q2 2022.

Based on Prostatis Group's 13F filing for Q2 2022, filed 23 Mar 2023.